| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 35.1 | 20.6 |
| Gross profit | 31.2 | 17.9 |
| Profit before tax | 8.0 | 0.4 |
| Net income | 7.0 | 0.8 |
| EPS (diluted, $ a share) | $0.17 | $0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +737.6% |
|---|---|
| Revenue, year on year | +70.7% |
| Gross margin | 88.8% |
| Operating margin | 20.3% |
10-Q filed with the SEC, NASDAQ: DCTH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Delcath Systems, Inc.: key numbers
- Share price
- $19.87Close, Nov 16
- Market cap
- $691M
- Shares outstanding
- 34.79MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Delcath Systems, Inc.
All →Delcath Systems Director Bridget A. Martell Sells $489K of Stock
Bridget A. Martell, Director, sold 22,500 shares of Delcath Systems, Inc. at $21.66 to $22.26 a share (average $21.71) in 2 transactions, worth $489K in total on Nov 12, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $489K
- Shares
- 22,500
- Average price
- $21.71
- Role
- Director
- Holding change
- -100.0%
- Trade date
- Nov 12, 2026
Delcath Systems Financial Results
Delcath Systems reported Q3 2026 total revenue of $35.1 million, a 70% increase year-over-year, driven by strong HEPZATO KIT sales in the U.S. The company achieved net income of $7.0 million and increased its full-year 2026 revenue guidance to a range of $115 million to $117 million.
- Term
- Q3 2026
“We are pleased with the continued momentum in our business, with meaningful progress across both commercial operations and clinical development. Growing physician experience with HEPZATO, strong engagement across our treatment center network, and increasing interest in its use alongside systemic therapies reinforce our confidence in the long-term opportunity.”
Gerard Michel, Chief Executive Officer of Delcath Systems